Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Please include your organization in your Zoom name.
- Click on your picture/name in Zoom
- Click on rename
- enter <name> - <organization>
Name | Organization | Present |
---|---|---|
Danielle Bancroft | Best Practice Software | |
Melva Peters | Jenaker Consulting | x |
Jean Duteau | Duteau Design | x |
John Hatem | Independent Consultant | x |
Scott Robertson | Kaiser Permanente | x |
Christof Gessner | HL7 Germany | |
Corey Spears | MITRE | |
Dave Hill | MITRE | |
Frank McKinney | POCP | x |
Isaac Vetter | Epic | |
Joseph Quinn (Joe) | Smile Digital Health | x |
Lawrence Lo | Columbia University HIT Student | |
Margaret Weiker | NCPDP | |
Matt Szczepankiewicz | Epic | |
Peter Sergent | HL7 New Zealand | |
Reed D. Gelzer | Trustworthy EHR | |
Shelly Spiro | Pharmacy HIT Collaborative | |
Stephen Chu | ADHA | x |
Tim McNeil | Surescripts | |
Kim Roberts | Pharmacy HIT Collaborative | |
Phung Matthews | 3M | |
Jack Brashier | Epic | |
Emmanuel Obasuyi | ||
Joel Montavon | PQA | |
Robb Young | PharmID | |
Christopher Isong | ||
Gary Schoettmer | NetRx | |
Courtney Bland | CVS / Aetna | |
Mark Neumuth | Aetna | |
Ed Millikan | FDA | |
Sanket Raval | CVS / Aetna | |
James Tcheng | ||
Peter Muir | ||
Joe Kelly | Surescripts | |
Peter Jordan | ||
Jose Costa Teixeira | x | |
Jeff Shick | USP | |
Kent Bulza | Artera |
Agenda Items and Notes
Outstanding Action Item List
Meeting Notes from previous meeting
- 2023-01-09 Agenda/Meeting Notes accepted by general consent
- January 2023 - Las Vegas January 2023 - Moved by John Hatem seconded by Jose Costa Texiera to approve minutes - Approved - 4-0-3
- September 2022 WGM Meeting - Baltimore - Moved by John Hatem seconded by Jose Costa Texiera to approve minutes - Approved - 6-0-1
Project Proposals
- Person Centric FHIR View - PSS-2153 - scope is unclear but Pharmacy doesn't need to be involved in the project.
Project Scope Statements
- Influenza Hospitalization Surveillance Network - PSS-2125 -
External Meeting Review
Catalog Updates (John Hatem)
- No meeting
Workflow Update (John Hatem)
- No Pharmacy specific updates
Healthcare Product Update (John Hatem)
- John to look at BDP Dispense Status
EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)
- Meeting to be held on Feb 1 - John and Scott attending - "Medication List Management and Reconciliation - 5pm Eastern
- in Conference call schedule
Potential Drug-Drug Interaction (PDDI) CDS IG
- no further action - remove from agenda
NCPDP Updates (NCPDP Members)
- no calls this week due to NCPDP meetings this week
- Digital Therapeutics push going on - looking to see who it could work in ambulatory care workflow
Pharmacist Consult Note (Scott)
- Publication Request - not ready yet - waiting for NCPDP approval
Pharmacy Templates
- Block Vote - dealt with at the WGM - Giorgio working on applying changes and then will bring forward a publication request
Specialty Medication Enrolment IG
- Block Vote - block vote was posted
a couple of responses received - no one indicated there was an issue
- Motion to approved proposed dispositions on the following items - moved by Frank McKinney - seconded by John Hatem - 6-0-0 - Approved
Key | Summary | Reporter | Resolution | Pre Applied |
Describe specialty medication and reason for uninitiated | Floyd Eisenberg | Persuasive | Yes | |
Combine the task type code systems into one code system | Rob McClure | Persuasive with Modification | Yes | |
Clarify how a prescriber will know specific pieces of information | Celine Lefebvre | Not Persuasive | ||
The Consent framework should be a reusable infrastructure element rather than being re-defined in domain-specific APIs/IGs | Ioana Singureanu | Not Persuasive | ||
Include "count" parameter if one match response allowed | Carmela A. Couderc | Persuasive | Yes | |
Change "ID" to "IDs" | Carmela A. Couderc | Not Persuasive with Modification | Yes | |
Defining URL should be anchored in THO. 1. | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 2 | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 3 | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 4. | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 5. | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 6 | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 7. | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 8 | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 9 | Joan Harper | Considered for Future Use | ||
Defining URL should be anchored in THO. 10 | Joan Harper | Considered for Future Use |
Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)
- Jean has a resource working on making the changes
- working on MedUsage name change -
- Has assigned a number of issues to Rosemary
- Feb 24 - all changes from ballot - then will be published as R5
- 3 open issues not voted on
Any Other Business
- Dosage Timing - Jose
- timing.repeat.when - doesn't have between meals
- this is a FHIR-I issues - related to FHIR-34124
- US Medication FHIR Implementation Guide - Jean will update to "Considered for Future Use" since IG was withdrawn
- WGM Meeting Room Request
- will be coming out - Co-chairs will watch for notice